市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Cingulate Inc. | 混合的 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -1.6 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 相对估值 | NA |
| 财务健康 | -1.8 |
| 宏观环境 | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | -0.60 |
|
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 2.40% |
| 机构持股比例 | 3.22% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Chicago Partners Investment Group Llc | 30 Sep 2026 | 110,737 |
| Bcv Asset Management Inc. | 30 Jun 2026 | 51,200 |
| Quantum Private Wealth, Llc | 30 Sep 2026 | 30,000 |
| Prospera Financial Services Inc | 30 Jun 2026 | 29,900 |
该时间范围内无数据。
该时间范围内无数据。
投资组合